Slovensko - slovenština - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - nimesulid - 29 - antirheumatica, antiphlogistica, antiuratica

Evropská unie - slovenština - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - Činidlá modifikujúce lipidy - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Evropská unie - slovenština - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - mačky - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinárneho lieku je výlučne uvedená pri všetkých troch skupín sú zamerané na rovnaký čas.

Evropská unie - slovenština - EMA (European Medicines Agency)

elanco gmbh - lotilaner, milbemycin oxime - endektocídov - psy - for use in dogs with, or at risk from, mixed infestations/infections of ticks, fleas, gastrointestinal nematodes, heartworm and/or lungworm.

Evropská unie - slovenština - EMA (European Medicines Agency)

vétoquinol sa - emodepside, praziquantel, tigolaner - anthelmintics, - mačky - for cats with, or at risk from, mixed parasitic infestations. the veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.

Evropská unie - slovenština - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imunosupresíva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).